CLINICAL_TRIALS
trial_result
· 2022-01-12
Clinical Trial Update: Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds [Phase 2, Phase 3]
Summary
A Phase 2/3 trial evaluating 0.25% Timolol Gel for healing surgical open wounds has completed to assess efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Wound of Skin, Wound Heal | Phase 2, Phase 3 | Status: COMPLETED